Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project

被引:10
作者
Braulke, Friederike [1 ]
Para, Servet [2 ]
Alt-Epping, Bernd [3 ]
Tewes, Mitra [4 ]
Baeumer, Markus [5 ]
Haberland, Birgit [6 ]
Mayer-Steinacker, Regine [7 ]
Hopprich, Anne [8 ]
de Wit, Maike [9 ]
Grabe, Michaela [10 ]
Bender-Saebelkampf, Sophia [11 ]
Wessling, Caroline [12 ]
Aulmann, Christoph [13 ]
Gerlach, Christina [3 ]
Regincos, Pascale [14 ]
Fischer, Ferdinand [15 ]
Haarmann, Soraya [16 ]
Huys, Tatjana [17 ]
Drygas, Sabine [18 ]
Rambau, Anett [19 ]
Kiani, Alexander [20 ,21 ]
Schnabel, Astrid [22 ]
Buhl, Christoph [23 ]
Seipke, Stefanie [24 ]
Hiemer, Sonja [25 ]
Polata, Silke [26 ]
Messmann, Maximilian [27 ]
Hansmeier, Anna [28 ]
Anastasiadou, Louiza [29 ]
Letsch, Anne [30 ]
Wecht, Daniel [31 ]
Hellberg-Naegele, Matthias [32 ]
Krug, Utz [23 ]
Wedding, Ulrich [33 ]
van Oorschot, Birgitt [2 ]
机构
[1] Univ Med Ctr Gottingen, Comprehens Canc Ctr, Gottingen, Germany
[2] Univ Hosp Wurzburg, Interdisciplinary Ctr Palliat Med, Wurzburg, Germany
[3] Univ Hosp Heidelberg, Dept Palliat Med, Heidelberg, Germany
[4] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Palliat Med, Essen, Germany
[5] Kliniken Maria Hilf GmbH Monchengladbach, Monchengladbach, Germany
[6] LMU Klinikum Munchen, Munich, Germany
[7] Ulm Univ, Comprehens Canc Ctr Ulm, Med Ctr, Ulm, Germany
[8] Univ Med Ctr Mainz, Dept Radiooncol & Radiotherapy, Mainz, Germany
[9] Vivantes Klinikum Neukolln, Canc Ctr Berlin Neukolln, Berlin, Germany
[10] Rems Murr Hosp Winnenden, Canc Ctr, Winnenden, Germany
[11] Univ Klinikum Erlangen, Erlangen, Germany
[12] Clemenshosp Munster, Munster, Germany
[13] Augsburg Univ Hosp, Augsburg, Germany
[14] Klinikum Stuttgart, Clin Hematol Oncol & Palliat Care, Stuttgart, Germany
[15] Hosp Ludwigshafen Rhein gGmbH, Ludwigshafen, Germany
[16] Kliniken Heilbronn GmbH, Fachklin Lowenstein, Lowenstein, Germany
[17] Univ Klinikum Giessen, Giessen, Germany
[18] Bruderkrankenhaus St Josef Paderborn, Paderborn, Germany
[19] Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany
[20] Klinikum Bayreuth GmbH, Erlangen, Germany
[21] Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany
[22] Univ Leipzig, Canc Ctr, Leipzig, Germany
[23] Hosp Leverkusen, Dept Oncol Hematol Palliat Med Special Pain Therap, Leverkusen, Germany
[24] Hannover Med Sch, Comprehens Canc Ctr, Hannover, Germany
[25] Klinikum St Georg Leipzig, Leipzig, Germany
[26] Evangelisches Waldkrankenhaus Berlin Spandau, Berlin, Germany
[27] Hosp St Elisabeth Straubing GmbH, Dept Palliat Med, Straubing, Germany
[28] Mathias Spital Rheine Ibbenburen, Rheine, Germany
[29] Agaplesion Markus Krankenhaus Frankfurt, Frankfurt, Germany
[30] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Kiel, Germany
[31] Univ Hosp Giessen & Marburg, Specialist Care Oncol & Palliat Care, Marburg, Germany
[32] Cantonal Hosp St Gallen, St Gallen, Switzerland
[33] Univ Hosp Jena, Dept Palliat Care, Klinikum 1, D-07747 Jena, Germany
关键词
Screening; Supportive; Palliative; MIDOS; IPOS; Cancer; PALLIATIVE CARE; REPORTED OUTCOMES; ADVERSE EVENTS; DISTRESS; IMPLEMENTATION; INTEGRATION; VALIDATION;
D O I
10.1007/s00432-023-04818-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeGuidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain knowledge on SC procedures in Oncology Centers (OCs) for advanced cancer patients and a first impression on the consequences of SC.MethodsThe KeSBa project consisted of three phases: pilot, 3 months screening and feedback phase. Participating OCs decided to use either the Minimal Documentation System (MIDOS) or the Integrated Palliative care Outcome Scale (IPOS) and defined the cutoff values for positive screening results.ResultsOut of 172 certified German OCs, 40 (23%) participated in the KeSBa pilot phase, 29 (16.8%) in the 3 months screening phase using MIDOS (n = 18, 58.6%) or IPOS (n = 11, 41.3%) and in the feedback round. 25/29 performed paper-based screening (86.2%). 2.963 CPs were screened. Results were documented for 1255 (42.2%, SC +) positive and 874 (29.5%, SC-) negative screenings depending on the center ' s schedules: 452 SC + CPs (28.4%) and 42 SC- CPs (2.6%) had contact to specialized palliative care or other supportive specialist teams afterwards, 458 SC + CPs (28.8%) and 605 SC- CPs (38.1%) remained in standard oncology care. In the feedback round missing resources (personal and IT) and improved communication were mentioned most often.ConclusionRoutine SC is feasible in advanced CPs treated in OCs but associated with considerable workload. In 42.2% of CPs SC was classified as positive, indicating the need of further diagnostics or professional judgment. SC requires staff and IT resources.
引用
收藏
页码:8829 / 8842
页数:14
相关论文
共 45 条
[11]  
German Guideline Programme in Oncology (German Cancer Society German Cancer Aid AWMF), S3 LEITL PSYCH DIAGN
[12]  
German Guideline Programme in Oncology (German Cancer Society German Cancer Aid AWMF), 2020, 128001OL AWMF
[13]   A systematic review of classifications systems to determine complexity of patient care needs in palliative care [J].
Grant, Matthew ;
de Graaf, Everlien ;
Teunissen, Saskia .
PALLIATIVE MEDICINE, 2021, 35 (04) :636-650
[14]   Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review [J].
Graupner, Caitlin ;
Kimman, Merel L. ;
Mul, Suzanne ;
Slok, Annerika H. M. ;
Claessens, Danny ;
Kleijnen, Jos ;
Dirksen, Carmen D. ;
Breukink, Stephanie O. .
SUPPORTIVE CARE IN CANCER, 2021, 29 (02) :573-593
[15]   Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) [J].
Hagelstein, V. ;
Ortland, I. ;
Wilmer, A. ;
Mitchell, S. A. ;
Jaehde, U. .
ANNALS OF ONCOLOGY, 2016, 27 (12) :2294-2299
[16]  
Hartmann C, 2021, MACHBARKEITSSTUDIE I
[17]   Development and validation of a core outcome measure for palliative care: the palliative care outcome scale [J].
Hearn, J ;
Higginson, IJ .
QUALITY IN HEALTH CARE, 1999, 8 (04) :219-227
[18]  
Herbert M, 2020, Z PSYCHOSOM MED PSYC, V66, P133, DOI 10.13109/zptm.2020.66.2.133
[19]   Understanding complexity - the palliative care situation as a complex adaptive system [J].
Hodiamont, Farina ;
Juenger, Saskia ;
Leidl, Reiner ;
Maier, Bernd Oliver ;
Schildmann, Eva ;
Bausewein, Claudia .
BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
[20]   Indicators of integration of oncology and palliative care programs: an international consensus [J].
Hui, D. ;
Bansal, S. ;
Strasser, F. ;
Morita, T. ;
Caraceni, A. ;
Davis, M. ;
Cherny, N. ;
Kaasa, S. ;
Currow, D. ;
Abernethy, A. ;
Nekolaichuk, C. ;
Bruera, E. .
ANNALS OF ONCOLOGY, 2015, 26 (09) :1953-1959